ClinicalTrials.Veeva

Menu
V

Velocity Clinical Research | San Bernardino, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cadisegliatin

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 2 total trials

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes (CATT1)

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.

Enrolling
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

Trial sponsors

Arcturus Therapeutics logo
vTv Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems